SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 353 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $942,000 | – | 8,525 | +141983.3% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 6 | -99.8% | 0.00% | -100.0% |
| Q1 2021 | $204,000 | -71.4% | 2,732 | -34.8% | 0.00% | -50.0% |
| Q4 2020 | $714,000 | -8.2% | 4,188 | -24.4% | 0.00% | 0.0% |
| Q3 2020 | $778,000 | +21.4% | 5,540 | -15.4% | 0.00% | -33.3% |
| Q1 2020 | $641,000 | -33.6% | 6,549 | -12.5% | 0.00% | 0.0% |
| Q4 2019 | $966,000 | +68.6% | 7,488 | -1.6% | 0.00% | +50.0% |
| Q3 2019 | $573,000 | -53.9% | 7,611 | -6.9% | 0.00% | -50.0% |
| Q2 2019 | $1,243,000 | +14.7% | 8,178 | -10.1% | 0.00% | 0.0% |
| Q1 2019 | $1,084,000 | +14.0% | 9,097 | +4.4% | 0.00% | 0.0% |
| Q4 2018 | $951,000 | -36.6% | 8,710 | -6.3% | 0.00% | -33.3% |
| Q3 2018 | $1,501,000 | +24.2% | 9,295 | +1.6% | 0.01% | +20.0% |
| Q2 2018 | $1,209,000 | +75.7% | 9,150 | -1.4% | 0.01% | +66.7% |
| Q1 2018 | $688,000 | +25.1% | 9,280 | -6.1% | 0.00% | +50.0% |
| Q4 2017 | $550,000 | +25.0% | 9,880 | +2.0% | 0.00% | 0.0% |
| Q3 2017 | $440,000 | – | 9,690 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |